Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics

• Angelo Gámez-Pozo ,

  Contributed equally to this work with: Angelo Gámez-Pozo, Lucía Trilla-Fuertes

  Affiliations Molecular Oncology & Pathology Lab, Instituto de Genética Médica y Molecular-INGEMM, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain, Biomedica Molecular Medicine SL, Madrid, Spain

  http://orcid.org/0000-0002-8931-0624

  ⨯
• Lucía Trilla-Fuertes ,

  Contributed equally to this work with: Angelo Gámez-Pozo, Lucía Trilla-Fuertes

  Affiliation Biomedica Molecular Medicine SL, Madrid, Spain

  ⨯
• Guillermo Prado-Vázquez,

  Affiliation Molecular Oncology & Pathology Lab, Instituto de Genética Médica y Molecular-INGEMM, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain

  ⨯
• Cristina Chiva,

  Affiliations Proteomics Unit, Center of Genomics Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain, Proteomics Unit, Universitat Pompeu Fabra (UPF), Barcelona, Spain

  ⨯
• Rocío López-Vacas,

  Affiliation Molecular Oncology & Pathology Lab, Instituto de Genética Médica y Molecular-INGEMM, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain

  ⨯
• Paolo Nanni,

  Affiliation Functional Genomics Centre Zurich, University of Zurich/ETH Zurich, Zurich, Switzerland

  ⨯
• Julia Berges-Soria,

  Affiliation Molecular Oncology & Pathology Lab, Instituto de Genética Médica y Molecular-INGEMM, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain

  ⨯
• Jonas Grossmann,

  Affiliation Functional Genomics Centre Zurich, University of Zurich/ETH Zurich, Zurich, Switzerland

  ⨯
• Mariana Díaz-Almirón,

  Affiliation Biostatistics Unit, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain

  ⨯
• Eva Ciruelos,

  Affiliation Medical Oncology Service, Instituto de Investigación Hospital Universitario Doce de Octubre-i+12, Madrid, Spain

  ⨯
• Eduard Sabidó,

  Affiliations Proteomics Unit, Center of Genomics Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain, Proteomics Unit, Universitat Pompeu Fabra (UPF), Barcelona, Spain

  ⨯
• Enrique Espinosa,

  Affiliations Medical Oncology Service, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain, CIBERONC. Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• Juan Ángel Fresno Vara

  * E-mail: juanangel.fresno@salud.madrid.org

  Affiliations Molecular Oncology & Pathology Lab, Instituto de Genética Médica y Molecular-INGEMM, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain, Biomedica Molecular Medicine SL, Madrid, Spain, CIBERONC. Instituto de Salud Carlos III, Madrid, Spain

  http://orcid.org/0000-0003-1527-1252

  ⨯